Abstract
Ibrutinib (Imbruvica (R)) is an oral irreversible inhibitor of Bruton's tyrosine kinase, a B-cell receptor (BCR) signalling kinase expressed by variou......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
